Eric Adams
Vorstandsvorsitzender bei INMED PHARMACEUTICALS INC.
Vermögen: 11 078 $ am 30.04.2024
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Andrew Hull | M | 61 | 8 Jahre | |
| Janet Grove | F | 57 | 2 Jahre | |
| Richard Glickman | M | 65 |
enGene, Inc.
 enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada. | 13 Jahre |
| Alexandra Mancini | F | - |
QLT, Inc.
 QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 8 Jahre |
| Colin Clancy | M | - | - | |
| Bryan Baldasare | M | 58 | 2 Jahre | |
| Bruce Sifton | M | - |
Ronin8 Technologies Ltd.
 Ronin8 Technologies Ltd. Environmental ServicesIndustrial Services Ronin8 Technologies Ltd. provides materials recovery facilities. It captures the metals in electronic waste without destroying the non-metals. The company was founded by Bruce Sifton and Peter Holgate in 2015 and is headquartered in Vancouver, Canada. | 9 Jahre |
| Michael Woudenberg | M | - | 6 Jahre | |
| Nicole Lemerond | F | 48 | 2 Jahre | |
| Eric Hsu | M | - | 6 Jahre | |
| Gerard Griffin | M | - | 2 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Julia G. Levy | M | 89 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 21 Jahre |
| Garner William | M | 58 | 6 Jahre | |
| Lawrence John Wood | M | 87 |
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada.
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 6 Jahre |
| Sazzad Hossain | M | - | 38 Jahre | |
| Catherine A. Sazdanoff | F | 68 | 3 Jahre | |
| Joshua Blacher | M | 52 | 1 Jahre | |
| Adam Daniel Cutler | M | 50 | 7 Jahre | |
| Paul Hastings | M | 64 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 4 Jahre |
| Jeffrey Charpentier | M | - | - | |
| Steven M. Rauscher | M | 70 | 18 Jahre | |
| John B. Thomas | M | - | 18 Jahre | |
| Martin Bott | M | - | 2 Jahre | |
| Cameron R. Nelson | M | 58 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 12 Jahre |
| David A. L. Owen | M | 85 | - | |
| Jonathan Tegge | M | 34 | 2 Jahre | |
| Bruce H. Phelps | M | - | 12 Jahre | |
| Robert Connelly | M | 63 | - | |
| Brenda Edwards | F | - | - | |
| David Stamler | M | 63 | 4 Jahre | |
| R. James Danehy | M | - | 21 Jahre | |
| Terese Gieselman | F | 62 | 5 Jahre | |
| John Robert Ducker | M | 64 | - | |
| David Laskow-Pooley | M | 69 | 6 Jahre | |
| Michael Fiechtner | M | - | 12 Jahre | |
| Bruce A. Beutel | M | 60 | 12 Jahre | |
| Michael DiTullio | M | 56 | 4 Jahre | |
| Peter C. Gonze | M | 74 | 3 Jahre | |
| Sandra Rose MacKay | F | 64 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 4 Jahre |
| Peter Hnik | M | - |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 7 Jahre |
| Martin A. Kaufman | M | - |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 4 Jahre |
| Azita Saleki-Gerhardt | M | 60 | 19 Jahre | |
| Paul Erickson | M | - |
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada. | 4 Jahre |
| William Henry Mullen | M | - | 3 Jahre | |
| Geertrui Vanhove | M | 59 | 2 Jahre | |
| Margo Heath-Chiozzi | M | 67 | 8 Jahre | |
| Patrick J. Eagan | M | 66 | 18 Jahre | |
| Lisa Giles | F | 65 | 10 Jahre | |
| Karsten Wellner | M | 63 | 12 Jahre | |
| David Granville | M | - |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 6 Jahre |
| Matt van Bergen | M | - | 2 Jahre | |
| Sharon Larkin | F | 60 | 23 Jahre | |
| Robert Michael | M | 53 | 19 Jahre | |
| Nancy Avila | F | 57 | 22 Jahre | |
| Bill Welch | M | 62 | 5 Jahre | |
| Edwin Levy | M | - |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 14 Jahre |
| Andrew Dunlop | M | 52 |
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada. | 3 Jahre |
| Robert Walder | M | 71 | 6 Jahre | |
| David Thompson | M | 82 | 21 Jahre | |
| O. Ralph Edwards | M | 89 | - | |
| Alan C. Mendelson | M | 76 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 6 Jahre |
| Paul D. Rubin | M | 70 | 6 Jahre | |
| Timothy Ring | M | 66 | 10 Jahre | |
| Christopher Kuebler | M | 70 | 8 Jahre | |
| Shi-Chung Ng | M | 69 | 11 Jahre | |
| Chung Chiang Hsu | M | 75 | 15 Jahre | |
| Irene C. Kerr | F | 74 | 10 Jahre | |
| Robert J. Koska | M | 66 | - | |
| Therese Hayes | F | - |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | - |
| Hugh Griffith | M | 56 | 6 Jahre | |
| Perry Karsen | M | 69 | 11 Jahre | |
| George F. Horner | M | 80 | 17 Jahre | |
| Robert Hooper | M | 77 | 4 Jahre | |
| William C. Houghton | M | 81 | 11 Jahre | |
| Gary Stevenson | M | - | 7 Jahre | |
| James J. Egan | M | 73 | 9 Jahre | |
| Douglas Liu | M | 62 | 10 Jahre | |
| David Milligan | M | 83 | 17 Jahre | |
| Bruce Colwill | M | - | 3 Jahre | |
| R. MacKay-Dunn | M | 73 |
enGene, Inc.
enGene, Inc. BiotechnologyHealth Technology enGene, Inc. develops therapeutic solutions for the treatment of metabolic diseases. It operates as a biotechnology company which develops a mucosal immunotherapy platform for treating several prevalent, chronic diseases including inflammatory bowel disease and diabetes. The firm also develops proprietary, non-integrating biopolymer based nucleotide DNA and siRNA delivery technology that facilitates localized delivery of immune-modulating proteins to the intestinal mucosa for treating various immune disorders. The company was founded in 1999 by Anthony T. Cheung, John C. Brown, Timothy J. Kieffer, and Francis John Gargiulo and is headquartered in Vancouver, Canada. | 7 Jahre |
| Todd Davis | M | 63 | 5 Jahre | |
| Terri Sebree | F | 66 | 8 Jahre | |
| Peter Holgate | M | - |
Ronin8 Technologies Ltd.
Ronin8 Technologies Ltd. Environmental ServicesIndustrial Services Ronin8 Technologies Ltd. provides materials recovery facilities. It captures the metals in electronic waste without destroying the non-metals. The company was founded by Bruce Sifton and Peter Holgate in 2015 and is headquartered in Vancouver, Canada. | - |
| Alain H. Curaudeau | M | 67 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 8 Jahre |
| William Newell | M | 66 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 3 Jahre |
| Matthew R. Hooper | M | 66 | 5 Jahre | |
| Alan S. Rosenthal | M | - | 6 Jahre | |
| Philippe G. Prokocimer | M | 74 | 7 Jahre | |
| Friedrich von Bohlen und Halbach | M | 60 | - | |
| Ken Galbraith | M | 61 |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | 14 Jahre |
| Sarah Li | F | - | - |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 47 | 51,65% |
| Kanada | 41 | 45,05% |
| Deutschland | 3 | 3,30% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Eric Adams
- Persönliches Netzwerk
